
浏览全部资源
扫码关注微信
吉林省中医药科学院,长春 130021
仇志锴,硕士,副主任医师,从事中医儿科研究,E-mail:qiuzhikai79@163.com
收稿日期:2022-06-07,
网络出版日期:2022-10-05,
纸质出版日期:2023-04-20
移动端阅览
仇志锴,王春莲,尤士军等.麻杏石甘汤合过敏煎加味对咳嗽变异性哮喘患儿症状改善及诱导痰炎性因子的影响[J].中国实验方剂学杂志,2023,29(08):214-219.
QIU Zhikai,WANG Chunlian,YOU Shijun,et al.Effect of Maxing Shigantang and Supplemented Guominjian Decoction on Symptoms and Inflammatory Cytokine Levels in Induced Sputum of Children with Cough Variant Asthma[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(08):214-219.
仇志锴,王春莲,尤士军等.麻杏石甘汤合过敏煎加味对咳嗽变异性哮喘患儿症状改善及诱导痰炎性因子的影响[J].中国实验方剂学杂志,2023,29(08):214-219. DOI: 10.13422/j.cnki.syfjx.202202226.
QIU Zhikai,WANG Chunlian,YOU Shijun,et al.Effect of Maxing Shigantang and Supplemented Guominjian Decoction on Symptoms and Inflammatory Cytokine Levels in Induced Sputum of Children with Cough Variant Asthma[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(08):214-219. DOI: 10.13422/j.cnki.syfjx.202202226.
目的
2
观察麻杏石甘汤合过敏煎加味改善咳嗽变异性哮喘(CVA)患儿临床症状及对其诱导痰炎性因子的影响。
方法
2
将医院2020年1月至2021年1月收治的118例CVA患儿纳为研究对象,采用随机数字表法将其均分为观察组与对照组,其中对照组接受常规西医治疗,观察组在对照组治疗基础上联用麻杏石甘汤合过敏煎加味,随访1个月,比较两组患儿咳嗽及伴随症状积分、痰诱导液炎性因子水平[白细胞介素-10(IL-10)、白细胞介素-5(IL-5)、肿瘤坏死因子-
α
(TNF-
α
)、中心粒细胞、嗜酸性粒细胞]、肺功能[用力肺活量(FVC)、第1秒用力呼吸容积(FEV
1
)、FEV
1
/FVC]及治疗效果,随访3个月,比较两组CVA患儿哮喘急性发作次数。
结果
2
该研究中未有病例脱落,与本组治疗前比较,两组咳嗽症状及伴随症状得分均明显降低(
P
<
0.05);治疗后与对照组比较,观察组咳嗽症状与伴随症状得分更低(
P
<
0.05),与本组治疗前比较,两组肺功能指标FVC、FEV
1
及FEV
1
/FVC均升高(
P
<
0.05);治疗后与对照组比较,观察组肺功能指标FVC、FEV
1
及FEV
1
/FVC水平更高(
P
<
0.05)。与本组治疗前比较,两组血清IL-10水平均升高,血清IL-5、TNF-
α
、中性粒细胞及嗜酸性粒细胞水平均下降(
P
<
0.05);治疗后与对照组比较,观察组血清IL-10水平更高,血清IL-5、TNF-
α
、中性粒细胞及嗜酸性粒细胞水平更低(
P
<
0.05)。观察组治疗有效率为86.44%(51/59),高于对照组的69.49%(41/59)(
χ
2
=4.933,
P
<
0.05)。两组治疗期间均未出现严重药物不良反应。观察组治疗3个月内急性复发次数为(1.09±0.18)次,低于对照组的(2.83±049)次(
P
<
0.05)。
结论
2
常规西医治疗基础上加服麻杏石甘汤合过敏煎加味汤能有效减轻CVA患儿气道炎症反应,控制患儿咳嗽症状,改善其肺功能,提高治疗效果,减少疾病急性复发频率,且治疗安全性高。
Objective
2
To investigate effect of Maxing Shigantang and supplemented Guominjian decoction on symptoms and levels of inflammatory cytokines in induced sputum of children with cough variant asthma (CVA).
Method
2
A total of 118 CVA children who were treated in our hospital from January 2020 to January 2021 were enrolled and randomized into the control group and the observation group with the random number table method. Control group received routine western medicine and the observation group was treated by routine western medicine, Maxing Shigantang, and supplemented Guominjian decoction. In the one-month follow-up, the scores of cough and accompanying symptoms, levels of inflammatory cytokines [interleukin-10 (IL-10), interleukin-5 (IL-5), tumor necrosis factor-
α
(TNF-
α
), neutrophil, eosinophil] in induced sputum, pulmonary function parameters [forced vital capacity (FVC), forced expiratory volume in one second (FEV
1
), FEV
1
/FVC], and treatment outcomes were compared between the two groups. Moreover, the frequency of acute asthma attacks during the three-month follow-up was also compared.
Result
2
No cases dropped out from this study. After treatment, the scores of cough and accompanying symptoms were decreased in both groups (
P
<
0.05) and were lower in observation group than in control group (
P
<
0.05). After treatment, FVC, FEV
1
, and FEV
1
/FVC were raised in both groups and were higher in observation group than in control group (
P
<
0.05). The increase in the level of IL-10 along with the decrease in levels of IL-5, TNF-
α
, neutrophil, and eosinophil in induced sputum was found in both groups after treatment (
P
<
0.05), and observation group had higher level of IL-10 and lower levels of IL-5, TNF-
α
, neutrophil, and eosinophil than the control group (
P
<
0.05). The effective rate was 86.44% (51/59) in observation group, which was higher than the 69.49% (41/59) in control group (
χ
2
=4.933,
P
<
0.05). No serious adverse reaction occurred in either group. The frequency of acute asthma attacks during the three-month follow-up was (1.09±0.18) in observation group, which was lower than the (2.83±049) in the control group (
P
<
0.05).
Conclusion
2
Routine western medicine combined with Maxing Shigantang and supplemented Guominjian decoction can effectively and safely alleviate the airway inflammatory responses, control the clinical symptoms, improve pulmonary function, and reduce the frequency of acute recurrence in the treatment of CVA children.
MORICE A H , MILLQVIST E , BIEKSIENE K , et al . ERS guidelines on the diagnosis and treatment of chronic cough in adults and children [J]. Eur Respir J , 2020 , 55 ( 1 ): 136 - 141 .
CORRAO W M . Pearls and pitfalls in the diagnosis of cough variant asthma [J]. Allergy Asthma Proc , 2018 , 39 ( 6 ): 466 - 467 .
江春燕 , 倪美良 , 姚伟光 . 止嗽散颗粒剂治疗小儿风邪犯肺型咳嗽变异性哮喘30例观察 [J]. 浙江中医杂志 , 2021 , 56 ( 1 ): 35 .
王宽锋 , 任华 , 王翠翠 , 等 . 孟鲁司特钠联合布地奈德雾化吸入对咳嗽变异性哮喘患儿肺功能的影响 [J]. 实用临床医药杂志 , 2019 , 23 ( 4 ): 41 - 43,46 .
关洋洋 , 刘璐佳 , 刘丽丽 . 升陷通络法治疗胸闷变异性哮喘的探讨 [J]. 中国中医急症 , 2021 , 30 ( 8 ): 1416 - 1419 .
徐方蔚 , 霍婧伟 , 陈海鹏 , 等 . 从痰论治儿童咳嗽变异性哮喘的Th1/Th2细胞功能调控机制的研究进展 [J]. 世界中西医结合杂志 , 2021 , 16 ( 6 ): 1169 - 1172 .
林荣军 , 王为达 , 潘玉娟 , 等 . 青岛市区0~14岁儿童哮喘流行病学调查 [J]. 青岛大学医学院学报 , 2002 , 38 ( 3 ): 202 - 205 .
赵嘉虹 , 阚璇 . 儿童咳嗽变异性哮喘发病机制及诊治进展 [J]. 国际儿科学杂志 , 2022 , 49 ( 2 ): 96 - 99 .
任晓婷 , 徐炎 , 孙丽平 . 麻杏石甘汤现代研究进展及展望 [J]. 吉林中医药 , 2020 , 40 ( 8 ): 1106 - 1109
董振华 , 季元 , 范爱平 . 祝谌予经验集 [M]. 北京 : 人民卫生出版社 , 1999 .
中华医学会儿科学分会呼吸学组慢性咳嗽协作组 , 《中华儿科杂志》编辑委员会 . 中国儿童慢性咳嗽诊断与治疗指南(2013年修订) [J]. 中华儿科杂志 , 2014 , 52 ( 3 ): 184 - 188 .
郑筱萸 . 中药新药临床研究指导原则 [M]. 北京 : 中国医药科技出版社 , 2002 : 60 - 66 .
于海洋 , 梁嫄 , 王有鹏 , 等 . 中医药治疗儿童咳嗽变异性哮喘的研究进展 [J]. 中国医药导报 , 2022 , 19 ( 11 ): 34 - 37 .
符牧 , 程钢 , 杨中川 , 等 . 布地奈德联合地塞米松雾化吸入治疗急性感染性咽喉炎的临床研究 [J]. 中国临床药理学杂志 , 2019 , 35 ( 23 ): 4 .
赵嫣虹 , 黄振炎 . 基于数据挖掘两广地区中医治疗咳嗽变异性哮喘的组方规律 [J]. 广东药科大学学报 , 2021 , 37 ( 2 ): 113 - 117 .
栗卿 , 陈宪海 . 从辛开苦降法论治胸闷变异性哮喘 [J]. 中国中医急症 , 2021 , 30 ( 1 ): 101 - 104 .
关洋洋 , 刘璐佳 , 杨阳 , 等 . 络病理论在小儿咳嗽变异性哮喘中的运用 [J]. 现代中西医结合杂志 , 2021 , 30 ( 20 ): 2224 - 2227 .
游伟玲 , 李晓珍 , 张锋 , 等 . 中西医结合治疗咳嗽变异性哮喘临床观察 [J]. 新中医 , 2017 , 49 ( 6 ): 40 - 42 .
CHEN L , HUANG M , XIE N . The effect of montelukast sodium plus budesonide on the clinical efficacy, inflammation, and pulmonary function in children with cough variant asthma [J]. Am J Transl Res , 2021 , 13 ( 6 ): 6807 - 6816 .
陈菲 , 虞敏 , 钟永红 , 等 . 中性粒细胞在哮喘中的地位和作用 [J]. 浙江大学学报:医学版 , 2021 , 50 ( 1 ): 123 - 130 .
王飞 , 季涛云 , 王亚军 , 等 . 咳嗽变异性哮喘患儿血清总IgE、VEGF、IL-4、IL-5、IL-13及外周血EOS表达水平与临床意义 [J]. 临床肺科杂志 , 2019 , 24 ( 2 ): 266 - 270 .
王晓明 , 许良葵 , 罗佳波 . 麻黄-桂枝药对抗炎、镇痛作用研究 [J]. 中药新药与临床药理 , 2020 , 31 ( 2 ): 179 - 184 .
耿胜男 , 谢鹏 , 李阳杰 , 等 . 基于网络药理学的麻杏石甘汤治疗支气管哮喘的作用机制分析 [J]. 药物评价研究 , 2020 , 43 ( 11 ): 2168 - 2175 .
李梅 . 麻杏石甘汤加减对老年支气管哮喘患者的疗效 [J]. 河南医学研究 , 2020 , 29 ( 12 ): 2243 - 2245 .
叶攀峰 , 姜毅 , 宋显相 , 等 . 自拟过敏煎辅助治疗对小儿哮喘患者肺功能及预后影响的研究 [J]. 中国中医急症 , 2019 , 28 ( 3 ): 464 - 467 .
0
浏览量
71
下载量
5
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621